Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jaad.2019.12.074DOI Listing

Publication Analysis

Top Keywords

comment "nonscarring
4
"nonscarring alopecia
4
alopecia systemic
4
systemic lupus
4
lupus erythematosus
4
erythematosus cross-sectional
4
cross-sectional study
4
study trichoscopic
4
trichoscopic histopathologic
4
histopathologic immunopathologic
4

Similar Publications

The genetic basis of pigmentation in alopecia areata.

Exp Dermatol

June 2017

Department of Dermatology, Second Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, Zhejiang, China.

Alopecia areata (AA) is a common hair loss disorder characterized by discrete, well demarcated areas of non-scarring terminal hair alopecia, with the calculated lifetime risk of ~2%. In past decades, linkage and GWA studies have implicated dozens of susceptibility genes/loci that are linked to the development of AA. Fischer et al performed a genome-wide CNV analysis of 585 AA patients and 1,340 controls in a European population.

View Article and Find Full Text PDF

Inhibiting Janus kinases to treat alopecia areata.

Nat Med

September 2014

Department of Dermatology, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, USA.

Alopecia areata is an immune-mediated, nonscarring form of hair loss. A new study using human clinical samples and a mouse model demonstrates that CD8αβ⁺NKG2D⁺ T effector memory cells mediate alopecia areata in part through Janus kinase (JAK) signaling and that alopecia areata might be treated with JAK inhibitors.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!